Cargando…

Lysosome-mediated chemoresistance in acute myeloid leukemia

Despite the outstanding advances in understanding the biology underlying the pathophysiology of acute myeloid leukemia (AML) and the promising preclinical data published lastly, AML treatment still relies on a classic chemotherapy regimen largely unchanged for the past five decades. Recently, new dr...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cuesta-Casanovas, Laia, Delgado-Martínez, Jennifer, Cornet-Masana, Josep M., Carbó, José M., Clément-Demange, Lise, Risueño, Ruth M.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	OAE Publishing Inc. 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992599/ https://www.ncbi.nlm.nih.gov/pubmed/35582535 http://dx.doi.org/10.20517/cdr.2021.122

Ejemplares similares

Prolactin receptor signaling induces acquisition of chemoresistance and reduces clonogenicity in acute myeloid leukemia
por: Cuesta-Casanovas, Laia, et al.
Publicado: (2023)

A Novel Family of Lysosomotropic Tetracyclic Compounds for Treating Leukemia
por: Carbó, José M., et al.
Publicado: (2023)

Dual lysosomal-mitochondrial targeting by antihistamines to eradicate leukaemic cells
por: Cornet-Masana, Josep M., et al.
Publicado: (2019)

Histamine receptor 1 is expressed in leukaemic cells and affects differentiation sensitivity
por: Cornet‐Masana, Josep M., et al.
Publicado: (2020)

Emetine induces chemosensitivity and reduces clonogenicity of acute myeloid leukemia cells
por: Cornet-Masana, Josep Maria, et al.
Publicado: (2016)

Repositioning of bromocriptine for treatment of acute myeloid leukemia
por: Lara-Castillo, María Carmen, et al.
Publicado: (2016)

Germ line variants in patients with acute myeloid leukemia without a suspicion of hereditary hematologic malignancy syndrome
por: Guijarro, Francesca, et al.
Publicado: (2023)

Treatment with G-CSF reduces acute myeloid leukemia blast viability in the presence of bone marrow stroma
por: Nomdedeu, Meritxell, et al.
Publicado: (2015)

A lysosome-targeted dextran-doxorubicin nanodrug overcomes doxorubicin-induced chemoresistance of myeloid leukemia
por: Zeng, Yunxin, et al.
Publicado: (2021)

Transcriptomic profile of intrinsically chemoresistant acute myeloid leukemia patients
por: Horibata, Sachi
Publicado: (2019)

Lysosomes in acute myeloid leukemia: potential therapeutic targets?
por: Rafiq, Sreoshee, et al.
Publicado: (2021)

Identification of galectin-1 as a novel mediator for chemoresistance in chronic myeloid leukemia cells
por: Luo, Wu, et al.
Publicado: (2016)

microRNAs and Acute Myeloid Leukemia Chemoresistance: A Mechanistic Overview
por: Gabra, Martino Marco, et al.
Publicado: (2017)

Targeting chemoresistance and mitochondria-dependent metabolic reprogramming in acute myeloid leukemia
por: Feng, Lili, et al.
Publicado: (2023)

Oxidative Stress and ROS-Mediated Signaling in Leukemia: Novel Promising Perspectives to Eradicate Chemoresistant Cells in Myeloid Leukemia
por: Trombetti, Silvia, et al.
Publicado: (2021)

Notch signalling drives bone marrow stromal cell-mediated chemoresistance in acute myeloid leukemia
por: Kamga, Paul Takam, et al.
Publicado: (2016)

Increased Expression of Micro-RNA-23a Mediates Chemoresistance to Cytarabine in Acute Myeloid Leukemia
por: Hatzl, Stefan, et al.
Publicado: (2020)

The Possible Importance of β3 Integrins for Leukemogenesis and Chemoresistance in Acute Myeloid Leukemia
por: Johansen, Silje, et al.
Publicado: (2018)

Lin28A/CENPE Promoting the Proliferation and Chemoresistance of Acute Myeloid Leukemia
por: Shi, Mingyue, et al.
Publicado: (2021)

Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Caiado, Francisco, et al.
Publicado: (2019)

Intra‐heterogeneity in transcription and chemoresistant property of leukemia‐initiating cells in murine Setd2(−/−) acute myeloid leukemia
por: Song, Jiachun, et al.
Publicado: (2021)

Role of SIRT1 in Chemoresistant Leukemia
por: Fajardo-Orduña, Guadalupe Rosario, et al.
Publicado: (2023)

XIAP inhibitors induce differentiation and impair clonogenic capacity of acute myeloid leukemia stem cells
por: Moreno-Martínez, Daniel, et al.
Publicado: (2014)

Targeting Lysosomes in Cancer as Promising Strategy to Overcome Chemoresistance—A Mini Review
por: Geisslinger, Franz, et al.
Publicado: (2020)

Serotonin receptor type 1B constitutes a therapeutic target for MDS and CMML
por: Banús-Mulet, Antònia, et al.
Publicado: (2018)

The human vault RNA enhances tumorigenesis and chemoresistance through the lysosome in hepatocellular carcinoma
por: Ferro, Iolanda, et al.
Publicado: (2021)

Autolysosomal activation combined with lysosomal destabilization efficiently targets myeloid leukemia cells for cell death
por: Shah, Harshit, et al.
Publicado: (2023)

Tetraspanin CD82 drives Acute Myeloid Leukemia chemoresistance by modulating Protein Kinase C alpha and β1 integrin activation
por: Floren, Muskan, et al.
Publicado: (2020)

Lysosomes in Stem Cell Quiescence: A Potential Therapeutic Target in Acute Myeloid Leukemia
por: Jain, Vaibhav, et al.
Publicado: (2022)

Disrupting the leukemia niche in the central nervous system attenuates leukemia chemoresistance
por: Jonart, Leslie M., et al.
Publicado: (2020)

Author Correction: Lineage tracing of acute myeloid leukemia reveals the impact of hypomethylating agents on chemoresistance selection
por: Caiado, Francisco, et al.
Publicado: (2019)

The NADPH oxidase NOX2 is a marker of adverse prognosis involved in chemoresistance of acute myeloid leukemias
por: Paolillo, Rosa, et al.
Publicado: (2022)

Transcriptional regulation of autophagy-lysosomal function in BRAF-driven melanoma progression and chemoresistance
por: Li, Shun, et al.
Publicado: (2019)

Cyanobacteria from Terrestrial and Marine Sources Contain Apoptogens Able to Overcome Chemoresistance in Acute Myeloid Leukemia Cells
por: Liu, Liwei, et al.
Publicado: (2014)

Osteopontin b and c isoforms: Molecular Candidates Associated with Leukemic Stem Cell Chemoresistance in Acute Myeloid Leukemia
por: Mirzaei, Akram, et al.
Publicado: (2017)

The Progression of Acute Myeloid Leukemia from First Diagnosis to Chemoresistant Relapse: A Comparison of Proteomic and Phosphoproteomic Profiles
por: Aasebø, Elise, et al.
Publicado: (2020)

Low frequency TP53 hotspot mutation contributes to chemoresistance through clonal expansion in acute myeloid leukemia
por: Yan, Bowen, et al.
Publicado: (2020)

Disruption of gap junctions attenuates acute myeloid leukemia chemoresistance induced by bone marrow mesenchymal stromal cells
por: Kouzi, Farah, et al.
Publicado: (2019)

Dual role of HDAC10 in lysosomal exocytosis and DNA repair promotes neuroblastoma chemoresistance
por: Ridinger, Johannes, et al.
Publicado: (2018)

Drug Sequestration in Lysosomes as One of the Mechanisms of Chemoresistance of Cancer Cells and the Possibilities of Its Inhibition
por: Hraběta, Jan, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_m3p5rhpteacak3sij19bodc87q